Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

Real-time Quote. Real-time Tradegate - 05/31 09:59:57 pm
90.001 EUR   -0.01%
05/30 MERCK KGAA : Professor Frank Stangenberg-Haverkamp receives the "Afr..
05/26 MERCK KGAA : Volunteering Giving back to the community EMD Serono em..
05/25 MERCK KGAA : to Present Data on Rebif® (interferon beta-1a) and Clad..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
05/25/2016 05/26/2016 05/27/2016 05/30/2016 05/31/2016 Date
90.04(c) 89.87(c) 89.96(c) 90.01(c) 89.95 Last
511 304 313 940 351 151 143 589 511 571 Volume
+1.04% -0.19% +0.10% +0.06% -0.07% Change
More quotes
Financials (€)
Sales 2016 15 109 M
EBIT 2016 3 123 M
Net income 2016 1 631 M
Debt 2016 10 919 M
Yield 2016 1,34%
Sales 2017 15 450 M
EBIT 2017 3 288 M
Net income 2017 1 763 M
Debt 2017 9 113 M
Yield 2017 1,43%
P/E ratio 2016 23,03
P/E ratio 2017 21,36
EV / Sales 2016 1,49x
EV / Sales 2017 1,34x
Capitalization 11 633 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.The company operates through following divisions: Healthcare, Performance Materials and Life Science, which comprise the Groups six businesses.The Healthcare division is sub divided into Biopharmaceuticals and Consumer... 
Sector
Pharmaceuticals
Calendar
06/04 | 03:00pmPresentation
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
01:05p MERCK KGAA : Fertility Solutions Partners with EMD Serono's Compassionate Care P..
05/30 MERCK KGAA : Professor Frank Stangenberg-Haverkamp receives the "African Allianc..
05/30 MERCK KGAA : Professor Frank Stangenberg-Haverkamp receives the “African A..
05/26 MERCK KGAA : Volunteering Giving back to the community EMD Serono employees clea..
05/25 MERCK KGAA : to Present Data on Rebif® (interferon beta-1a) and Cladribine Table..
05/24 MERCK KGAA : Nigéria recebe donativo recorde de praziquantel A Merck fornece cer..
05/24 MERCK : Le Nigeria reçoit un don record de praziquantel Merck fournit cette anné..
05/24 MERCK : Nigeria Receives Record Praziquantel Donation Merck supplies around 34 m..
05/22 MERCK KGAA : SAFC earns point on the road vs OKC Energy FC
05/22 MERCK KGAA : SAFC derrotó 3-1 a Corinthians FC y va a la tercera ronda de Lamar ..
More news
Sector news : Specialty & Advanced Pharmaceuticals
06:15pDJTEVA PHARMACEUTICAL : FDA Rejects Teva's Application for Huntington's Drug -- 3r..
05:58p OTSUKA : Announces New, Additional Certification Under "ISO 22301", the Internat..
05:37p JOHNSON & JOHNSON : European Commission Approves TREVICTA® (paliperidone palmita..
04:31p BRISTOL MYERS SQUIBB : to Take Part in Goldman Sachs 37th Annual Global Health C..
04:29p SUN PHARMACEUTICAL : Pharma reports Q4 & FY16 results
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
2014Prices move higher as positive news are released
2014A gap-filling is anticipated
More Strategies
News from SeekingAlpha
05/19 Merck KGaA reports Q1 results
05/16 Merck KGaA Deserves A Place In A Quality Portfolio
05/01 WEEK IN REVIEW : Beijing's Dehaier Raises $20 Million For Smart Medical Devices
04/20 Keytruda Threatens Avelumab, But Feels More Heat From Opdivo
04/18 BeiGene's BGB-283 shows positive effects in early-stage cancer study in diffi..
Advertisement
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions